Development and Evaluation of Physiologically Based Pharmacokinetic Drug-Disease Models for Carvedilol in Adults and Children by Using Population Based Simulations and Real Data

@inproceedings{BPharm2016DevelopmentAE,
  title={Development and Evaluation of Physiologically Based Pharmacokinetic Drug-Disease Models for Carvedilol in Adults and Children by Using Population Based Simulations and Real Data},
  author={M.Phil Rasool Muhammad Fawad B.Pharm},
  year={2016}
}

References

Publications referenced by this paper.
SHOWING 1-10 OF 88 REFERENCES

In vitro identification of the human cytochrome P450 enzymes involved in the metabolism of R(+)- and S(-)-carvedilol.

  • Drug metabolism and disposition: the biological fate of chemicals
  • 1997
VIEW 8 EXCERPTS
HIGHLY INFLUENTIAL

Stereoselective disposition of carvedilol is determined by CYP2D6.

  • Clinical pharmacology and therapeutics
  • 1995
VIEW 14 EXCERPTS
HIGHLY INFLUENTIAL

Pharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blocker

  • European Journal of Clinical Pharmacology
  • 1987
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Pharmacokinetics and disposition of carvedilol in humans.

  • Journal of cardiovascular pharmacology
  • 1987
VIEW 15 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…